Fig. 1: Incidence of toxicities.

a Fraction of patients experiencing various toxicities during the treatment and follow-up periods, b Fraction of patients whose toxicities appeared only after the end of treatment.

a Fraction of patients experiencing various toxicities during the treatment and follow-up periods, b Fraction of patients whose toxicities appeared only after the end of treatment.